EBOS reports solid growth in Underlying earnings as the business prepares for the next wave of growth in FY20
Full Year Highlights
- Underlying EBITDA $261.6 million (up 4.6%) & Underlying NPAT $144.4 million (up 5.2%)
- Strong operating cash flow before capital expenditure of $118.5m
- Final dividend declared of NZ 37 cents per share (up 4.2%)
- Completed several strategic acquisitions during the period for a total investment of $93.6 million
- Signed agreement with Chemist Warehouse Group (CWG) for the exclusive wholesale distribution of pharmaceutical products which commenced 1 July 2019
- Commissioned operations at our new world-class, highly automated, pharmaceutical Distribution Centre in Brisbane and opened our new Contract Logistics facility in Sydney
- Raised equity of NZ$175million in May 2019 in support of future acquisitions and organic growth opportunities
EBOS Group Limited (EBOS) today announced solid growth in underlying earnings for the 2019 financial year.
Commenting on the year, Chief Executive Officer John Cullity said that “2019 has been a year of high activity and strategically important for the Group as it has set the foundation for the next wave of growth. We commenced operations in two brand new facilities in Brisbane and Sydney providing further warehouse capacity. We also moved to 100% ownership of TerryWhite Chemmart, signed the Chemist Warehouse Group pharmaceutical contract and retained Blooms The Chemist, one of our largest independent pharmacy group customers. These were all great outcomes for our Community Pharmacy division.”
“The Group continues to operate in highly competitive markets and this year was no exception. We have withstood the changing market dynamics and competitive pressures and delivered both solid underlying earnings growth and another strong cash result.”
“The year saw us complete several strategic acquisitions building out both our Healthcare and Animal Care businesses. The total value of investments for the year was $93.6m and included a move to 100% ownership of Terry White Group (TWG) along with another three small-to-medium sized bolt on acquisitions.” Mr Cullity said.